Related Experiment Video
Updated: Jul 13, 2026
10:27
Methods to Increase the Sensitivity of High Resolution Melting Single Nucleotide Polymorphism Genotyping in Malaria
Published on: November 10, 2015
Structural polymorphism and diversifying selection on the pregnancy malaria vaccine candidate VAR2CSA
Joseph Bockhorst1, Fangli Lu, Joel H Janes
1Microsoft Research, Seattle, WA, USA.
Molecular and Biochemical Parasitology
|August 3, 2007
Summary
VAR2CSA, a pregnancy malaria vaccine candidate, shows ancient origins and extensive recombination. Its polymorphic segments, concentrated in flexible loops, are targeted by host antibodies, guiding vaccine development.
Area of Science:
- Immunology
- Parasitology
- Computational Biology
Background:
- VAR2CSA is a key target for a pregnancy malaria vaccine.
- Sequence polymorphism in VAR2CSA complicates vaccine development.
- Understanding VAR2CSA variation is crucial for effective vaccine design.
Purpose of the Study:
- To investigate geographic variation and selection pressure on VAR2CSA.
- To analyze structural patterns of VAR2CSA sequence polymorphism.
- To develop novel computational methods for studying recombining genes.
Main Methods:
- Obtained and analyzed 106 partial or full-length var2CSA sequences.
- Applied novel computational methods and 3D modeling.
- Developed a new phylogenetic approach incorporating recombination.
Main Results:
- Identified structural patterns of VAR2CSA variation with segments of limited diversity.
- Found two to three basic types characterizing most parasite samples, with ancient origins.
- Demonstrated extensive recombination between var2CSA alleles, forming a mosaic structure.
- Localized polymorphic segments to flexible loops in DBL domains, with distinct selection patterns.
Conclusions:
- VAR2CSA evolution is shaped by recombination and selection on specific domains.
- Novel phylogenetic methods are effective for analyzing highly recombining genes.
- Findings provide insights into VAR2CSA's immunoevasive ligand function.
- This work advances understanding for pregnancy malaria vaccine development.
Related Concept Videos
01:29Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
01:05Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
02:26Comparing Copy Number Variations and SNPs
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:25Genetic Variation
Genetic variation is the diversity in DNA sequences found among individuals of the same species. This diversity is crucial for a species' survival because it helps organisms adapt to environmental changes. Genetic variation begins with fertilization, where an egg and sperm cell merge. Each of these cells carries 23 chromosomes, up to 46 in the fertilized egg. Chromosomes are long DNA strands that contain genes, the basic units of heredity.
Genes exist in different versions called alleles, which...
Genes exist in different versions called alleles, which...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...